Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · August 15, 2024

Prognostic Value of the 21-Gene Breast Recurrence Score Assay for HR+/HER2− Advanced Breast Cancer

Breast Cancer Research and Treatment

 

Additional Info

Breast Cancer Research and Treatment
Prognostic value of the 21-Gene Breast Recurrence Score® assay for hormone receptor-positive/human epidermal growth factor 2-negative advanced breast cancer: subanalysis from Japan Breast Cancer Research Group-M07 (FUTURE trial)
Breast Cancer Res Treat 2024 Jun 26;[EPub Ahead of Print], T Iwamoto, N Niikura, K Watanabe, T Takeshita, Y Kikawa, K Kobayashi, N Iwakuma, T Okamura, T Kobayashi, Y Katagiri, M Kitada, N Tomioka, Y Miyoshi, H Shigematsu, M Miyashita, H Ishiguro, N Masuda, S Saji

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading